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Lipases are successfully applied in enantioselective
biocatalysis. Most lipases contain a lid domain con-
trolling access to the active site, but Bacillus subtilis
Lipase A (LipA) is a notable exception: its active site
is solvent exposed. To improve the enantioselectivity
of LipA in the kinetic resolution of 1,2-O-isopropyli-
dene-sn-glycerol (IPG) esters, we replaced a loop
near the active-site entrance by longer loops originat-
ing from Fusarium solani cutinase and Penicillium
purpurogenum acetylxylan esterase, thereby aiming
to increase the interaction surface for the substrate.
The resulting loop hybrids showed enantio-
selectivities inverted toward the desired enantiomer
of IPG. The acetylxylan esterase-derived variant
showed an inversion in enantiomeric excess (ee)
from12.9% to+6.0%,whereas the cutinase-derived
variantwas improved toaneeof+26.5%.Theenantio-
selectivity of the cutinase-derived variant was further
improved by directed evolution to an ee of +57.4%.
INTRODUCTION
Stricter regulations of the US Food and Drug Administration
(FDA) have imposed the use of enantiopure pharmaceuticals
(Blaser et al., 2005; Breuer et al., 2005), which has led to an
increased demand of the chemical industry for enantioselective
catalysts. Enzymes can offer the necessary high enantio-
selectivity combinedwith efficient catalysis and few by-products
(Schmid et al., 2001; Zhao et al., 2002). A prime example of a suc-
cessful application of an enzyme in enantioselective biocatalysis
is provided by lipases. These enzymes are active in both aque-
ous and low-water media, and they can convert a large variety
of (synthetic) molecules. The most common application of li-
pases is in the preparation of chiral building blocks, especially
by kinetic resolution of racemic mixtures (Beisson et al., 2000).
To understand the molecular details of catalysis by lipases, 3D
structures of 38 different lipases have been elucidated. All struc-
tures show an a/b-hydrolase fold, with the catalytic serine lo-
cated at the so-called nucleophile elbow (Beisson et al., 2000;782 Chemistry & Biology 15, 782–789, August 25, 2008 ª2008 ElsevHolmquist, 2000), and the other two catalytic triad residues,
Asp and His, in close proximity. Most lipases contain a lid
domain controlling access to the active site (Eggert et al.,
2004). The interaction of the enzyme with lipid aggregates in-
duces the displacement of the lid, which makes the active site
accessible to individual substrate molecules and increases the
catalytic activity. This phenomenon is known as interfacial acti-
vation. The amino acid composition of the lid has been shown
to affect both the specificity as well as the enantioselectivity of
lipases (Beisson et al., 2000; Secundo et al., 2004; Verger, 1997).
TheBacillus subtilis 168 Lipase A (LipA) is of particular interest,
since it does not show interfacial activation. In agreement with
this, it has been found that it does not contain a lid, and that its
active site is solvent exposed (Van Pouderoyen et al., 2001).
Due to its small size and relatively low molecular mass (181
amino acid residues, 19 kDa), the B. subtilis LipA can be
regarded as a minimal a/b-hydrolase fold enzyme (Dartois
et al., 1992, 1994; Dro¨ge et al., 2006; Lesuisse et al., 1993; Van
Pouderoyen et al., 2001). Other small a/b-hydrolase fold ester-
ases without a lid include the 21 kDa cutinase from Fusarium
solani (197 amino acid residues; PDB entry 1CEX [Longhi et al.,
1997; Martinez et al., 1992]) and the 22 kDa acetylxylan esterase
(AXE) from Penicillium purpurogenum (207 residues; PDB entry
1G66 [Ghosh et al., 1999]). Their 3D structures are similar to
that of LipA, with five parallel b strands and four a helices, and
their active sites are also solvent exposed. However, the sub-
strate-binding cleft of LipA is shallower and wider than those of
1CEX and AXE; the loops lining the cleft of LipA are shorter
and do not extend as much from the core of the protein as in
1CEX and AXE (Van Pouderoyen et al., 2001).
In this study, we investigated the effect on the activity and
enantioselectivity of LipA of replacing a short active-site-lining
loop by the longer loops from 1CEX and AXE, thereby extending
this loop by three or two amino acids, respectively. It was shown
previously that this active-site-lining loop is of key importance to
the enantioselectivity of LipA (Dro¨ge et al., 2006). We hypothe-
sized that this replacement could increase the interaction sur-
face with the substrate and affect its enantioselectivity. Indeed,
we found that the loop replacement yielded LipA variants with
improved enantioselectivity. The AXE-derived variant showed
a change in enantiomeric excess (ee) from 12.9% to +6.0%,
whereas the cutinase-derived variant was improved to an ee
of +26.5%. The enantioselectivity of the cutinase-derived variantier Ltd All rights reserved
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of +57.4%.
RESULTS
Modeling of the Loop Mutants
B. subtilis LipA, as well as F. solani cutinase (1CEX) and P. pur-
purogenum acetylxylan esterase (AXE), can be regarded as
a minimal a/b-hydrolase fold enzyme, as it is lacking a lid do-
main. LipA shares 14% homology with 1CEX (Q-score of 0.29,
SSM server http://www.ebi.ac.uk/msd-srv/ssm [Krissinel and
Henrick, 2005]) as well as with AXE (Q-score of 0.28). The 3D
structure ofB. subtilis LipA is similar to those of 1CEX and P. pur-
purogenum AXE, superimposing with rmsd values of 1.9 A˚ and
2.9 A˚, respectively (Van Pouderoyen et al., 2001) (Figure 1A).
Several residues of the loop from residue 12 to residue 21 line
the hydrophobic pocket that holds the IPG moiety of the IPG
phosphonate inhibitors covalently bound to LipA (Dro¨ge et al.,
2006). Among these residues, N18 has been previously sug-
gested to be important for the enantioselective properties of
LipA (Dro¨ge et al., 2006; Van Pouderoyen et al., 2001). Therefore,
residues 12–20 were chosen for exchange with the correspond-
ing loop from cutinase (residues 42–53). Modeling this longer
loop in the LipA 3D structure by using the SWISS-MODEL server
(http://swissmodel.expasy.org [Arnold et al., 2006]) (Figures 1B
and 1C) suggests that the first b strand in LipA, which runs
from residue 3 to residue 11, is elongated with a Ser and a Thr
at positions 12 and 13, respectively, after which the peptide
chain makes a turn at a E14 and, via T15, returns to a G16, which
occupies a position equivalent to G13 in the parent LipA mole-
cule. In this way, a larger binding surface is created for IPG
with residues that may interact with IPG, which are S12, T13,
N17 and L21, and E14 and T15.
Residues 11–21 were chosen for exchange with the corre-
sponding loop from AXE (residues 12–23). From the SWISS-
MODEL-generated structure, shown in Figures 1D and 1E, it
can be seen that the first b strand (residues 3–11 in LipA) is again
elongated by two residues, now E11 and T12. The loop makes
a turn at T13 and returns to S15 (equivalent to G13 in LipA) via
A14. Here, residues that may interact with IPG are E11, T12,
A14, and S20.
Characterization of the Loops
The LipA wild-type loop was replaced by the two loops
described above. The resulting constructs were sequenced to
verify their nucleotide sequences, which were found to be cor-
rect. From SDS-PAGE analysis, it was seen that the loop hybrids
were translocated to the periplasmic space (Figure 2). The
expression of the loop hybrids was found to be comparable
to that of wild-type LipA. A first screen on activity by using
p-nitrophenyl caprylate showed a conversion to the yellow
p-nitrophenol by both loop variants. The activity and enantio-
selectivity in the conversion of IPG butyrate is given in Table 1.
The activity was found to be comparable to that of wild-type
LipA, with conversions of 20.9% and 29.7% for the AXE
and 1CEX loop variants, respectively, versus 28.2% for wild-
type LipA. However, compared to the wild-type enzyme (ee
of 12.9%) the enantioselectivity of the variants was inverted
toward the desired enantiomer of IPG. The AXE variant showedChemistry & Biology 15, 7a slight improvement in ee to +6.0%, whereas the cutinase-
derived variant was improved to an ee of +26.5%. Interestingly,
the cutinase wild-type enzyme also showed an enantioprefer-
ence toward S-(+)-IPG, with an ee of +40.5% (Table 1). The KM
value of the 1CEX-derived variant toward S-(+)-IPG was not sig-
nificantly lowered compared to the wild-type (Table 2). The 1CEX
hybrid appeared to be the more promising variant in terms of
enantioselectivity. Since the models showed that L21 may inter-
act with IPG, and that L21 is in a position equivalent to that of
N18 in wild-type LipA, a residue that has been shown to be im-
portant for the enzyme’s enantioselectivity (Dro¨ge et al., 2006;
Eggert et al., 2005), L21 was selected for saturation mutagenesis
and subsequent selection.
Directed Evolution of the 1CEX Loop
After the transformation of Escherichia coli HB2151, a mutant
library on position L21 consisting of 1250 clones was obtained.
Sequence analysis of ten clones revealed that one clone had
no mutation at position 21 and that two clones had a mutation
to serine, whereas the other seven clones all had a different
amino acid mutation. Considering its size of 1250 clones and
the use of a NNS codon, the library was found to have sufficient
variability at position 21.
The library was subjected to the growth-selection assay,
based on an aspartate auxotrophy (Boersma et al., 2008). Mini-
mal mediumwas supplemented with enantiopure IPG coupled to
aspartate, whereas selection pressure was increased by the ad-
dition of an enantiopure IPG phosphonate. All selected mutants
showed a further improvement of the inverted enantioselectivity
from an ee of +26.4% to an ee of +57.4% for the best variant,
L21Q (Figure 3). Selection was in favor of mutation L21G, which
was observed six times. Remarkably, the parent 1CEX sequence
was not retrieved. Together with the L21Q mutation, which was
observed three times, the L21G mutant showed an activity to-
ward the IPG ester comparable to that of the parent loop mutant
(29.7% for the parent loop mutant versus 22.4% and 28.3% for
L21G and L21Q, respectively). As thesemutations had an advan-
tageous effect on the enantioselectivity, as reflected in an
improved ee value, the L21G and L21Q mutants were further
characterized. The expression of the 1CEX parent variant and
mutants L21G and L21Q in the periplasm was found to be
comparable (Figure 2). All three had a lowered affinity toward
S-(+)-IPG, although this value was not significant (p > 0.05;
Table 2).
Due to their frequency of retrieval and their enantioselectivity,
L21G and L21Q were used to parent a second mutant library at
position T20. According to themodel, residue T20was unlikely to
interact with IPG, in contrast to residue L21. Hence, no effect on
the enzyme’s enantioselectivity was expected upon mutagene-
sis of T20. After transformation of E. coli HB2151, two mutant
libraries consisting of 1000 clones were obtained. Sequence
analysis of ten clones from each library revealed that all variants
showed a different mutation. Thus, the libraries were found to be
satisfactory. Then, both libraries were used in the growth-selec-
tion assay, colonies were picked, the periplasm was isolated,
and the activity and enantioselectivity toward racemic IPG buty-
rate was determined (Figure 4). The highest improvement in ee
was observed for variant T20K/L21G, from an ee of +31.7% to
an ee of +67.7%. However, most variants showed a significant82–789, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 783
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In contrast to the first selection round on position L21, in this
round the parent sequence T20T/L21G was selected for as
well, although changes at the DNA level had occurred. For the
L21Q parent, a loss in ee was observed, from +52.0% for
L21Q itself to an ee value as low as +14.9% for the T20C/L21Q
mutant. Selected variants showed activities similar to that of
the L21Q parent.
DISCUSSION
All lipases share the a/b-hydrolase fold, and most lipases have
an a helix acting as a mobile lid controlling access to the active
site. The lid region modulates not only the activity of the enzyme,
but also its selectivity (Akoh et al., 2004; Brocca et al., 2003; Car-
rie`re et al., 1997; Dugi et al., 1995; Secundo et al., 2004; Seiza-
buro et al., 2005). Furthermore, mutations in the lid region can
affect substrate preference and thermostability (Santarossa
et al., 2005), and alterations of the enzyme’s enantioselectivity
have been described as well (Holmquist and Berglund, 1999).
Thus, the role of the lid is more complicated than simply control-
ling access to the enzyme active site. In contrast, some lipases
have been reported to have a solvent-exposed active site with-
out a lid-like structure. An example of such a hydrolase is the
B. subtilis LipA. In this study, we explored the feasibility of insert-
ing somewhat longer loops near the active site in this enzyme.
F. solani cutinase and P. purpurogenum acetylxylan esterase
were previously identified as structural homologs to LipA (Van
Pouderoyen et al., 2001). These enzymes feature the a/b-hydro-
lase fold as well, which enables rational mutagenesis and loop
swapping. A loop near the active site was chosen for the ex-
change, as this loop has been indicated to be important for the
enantioselectivity of the enzyme. Previously, position N18 within
the wild-type loop was shown to affect enantioselectivity in such
a way that enantiopreference was inverted toward the desired
enantiomer of IPG, possibly by a better accommodation of the
S-enantiomer in the active-site pocket of LipA (Dro¨ge et al.,
2006). Eggert et al. (2004) applied loop swapping to B. subtilis
LipA as well. In contrast to the present study, they used the
loop consisting of residues 39–51 of B. subtilis LipA, which is
more remote from the active site. That loop was exchanged for
loops from 1CEX (9 residues), AXE (10 residues), and human
pancreatic lipase (25 residues). Instead of extending an active-
site-lining loop, as presented in our work, it was hypothesized
that the active site was now more shielded from the solvent.
Their variants were enzymatically active on p-nitrophenyl palmi-
tate or on tributyrin, although they had lower activity than the
wild-type enzyme. A change in enantioselectivity was not deter-
mined. Based on our present work and that of Eggert et al.
(2004), LipA appears to be compliant to loop swapping, in agree-Chemistry & Biology 15, 7ment with the versatile a/b-hydrolase scaffold that can accom-
modate many insertions and deletions (Nardini and Dijkstra,
1999).
The lack of a lid domain in LipAmay explain its low enantiopre-
ference toward the substrate of interest, IPG. Therefore, we as-
sessed the effect of loop swapping/extension on the activity and
the enantioselectivity of LipA in the conversion of racemic IPG
butyrate. The constructed loop hybrids showed a conversion
of IPG butyrate comparable to wild-type LipA. An inversion
of the enantioselectivity was observed for both loop variants,
although the KM toward the desired enantiomer, S-(+)-IPG,
was not significantly lowered. This indicates that the affinity of
the enzyme for the desired substrate has not significantly
changed.
The increased enantioselectivity might suggest that the de-
sired enantiomer binds more productively. However, since 7%
of all LipA amino acids were altered, and since the changed
amino acids are near the active site, we cannot exclude other
explanations. The models suggest that the increased enantiose-
lectivity may be due to an improved interacting surface with the
S-enantiomer compared to the wild-type enzyme, since more
residues are available for interaction with the substrate IPG. In
the wild-type LipA, I12 functions in the stabilization of the transi-
tion state, being part of the preformed oxyanion hole. A15, F17,
and N18 play a role in substrate binding. For the variant with
the inserted AXE loop, the change in enantioselectivity wasmod-
est. Here, the nature of the binding pocket is most probably de-
termined by E11, T12, A14, and S20, the residues closest to the
IPG phosphonate inhibitor (Figures 1D and 1E). The active site
might still be able to accommodate both enantiomers reasonably
well, as hardly any enantiopreference is observed. For the cuti-
nase loop variant, the change in enantioselectivity was more
pronounced. This variant has three extra amino acid residues
compared to the wild-type LipA, thereby possibly creating a
more improved interaction surface for S-(+)-IPG. For this mutant,
the residues closest to the IPG phosphonate inhibitor are S12,
T13, N17, and L21 (Figures 1B and 1C). In addition, E14 and
T15 may have an effect on the interaction with IPG.
Figure 2. Expression of the Variants in the Periplasm of E. coli
HB2151 on SDS-PAGE Gel
A total of 25 mg variant 1CEX (lane 2), 1CEX L21G (lane 4), and 1CEX L21Q
(lane 5) was loaded.Wild-type LipA (lane 1) and an empty E. coliHB2151 strain
(lane 3), as well as purified LipA (lane 6), were taken as a control. Note that
the expressed proteins run slightly higher due to a His tag.Figure 1. Models of the Constructed Loop Variants Superimposed on LipA
(A) Alignment of LipA with cutinase and acetylxylan esterase in the region of residues 11–20, the region of loop replacement.
(B) Replacement of LipA residues 11–20 (light blue) with cutinase residues 41–53 (yellow); the phosphonate ester of S-(+)-IPG bound to LipA is shown in stick
representation.
(C) Stick representation of the cutinase loop.
(D) Replacement of LipA residues 11–20 (light blue) with acetylxylan esterase residues 12–23 (green); the phosphonate ester of S-(+)-IPG bound to LipA is shown
in stick representation.
(E) Stick representation of the acetylxylan esterase loop.82–789, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 785
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point for further optimization of the enantioselectivity by directed
evolution (Bloom et al., 2005; Reetz, 2004). However, enantiose-
lectivity being far from optimal, site-directed mutagenesis was
applied to residue L21 in the exchanged loop region. This residue
is at a position equivalent to N18 in thewild-type LipA, which pre-
viously has been shown to be important for the interaction with
the substrate IPG (Dro¨ge et al., 2006) and might therefore be
important for the enzyme’s enantioselectivity as well. Impor-
tantly, an improvement of enantioselectivity was observed for
all selected variants. Mutants with a somewhat shorter side
chain were favored in the selection. Indeed, mutant L21G was
selected for six times. Additionally, the selected variants L21A
and L21V showed high enantioselectivities as well. Due to their
smaller side chains compared to leucine, a more compact fold-
ingmight be possible. A glutamine residuewas selected for three
times; since it is a more polar residue and has a bigger side
chain, more subtle changes will take place, leading to an
improved enantioselectivity. The improved enantioselectivity
suggests that residue L21 is indeed in interacting distance to
IPG, thus corroborating the SWISS-MODEL-generated struc-
ture. Being in an equivalent position as N18 in the LipA wild-
type, L21 thus also has an important influence on enantioselec-
tivity. This observation might be substantiated by the fact that
a similar improvement of the enantioselectivity was not observed
when position T20 was mutated. Alhough these mutations re-
sulted in somewhat less active variants, the enantioselectivity
was equal to or less than the enantioselectivity of the respective
parent loop mutant.
In conclusion,wehavedesignedandengineered two lipasehy-
bridsbyexchanging stretchesof aminoacids.Bychanginga loop
near the active site, lipase hybrids were created with inverted
enantioselectivities compared to the wild-type parent enzyme.
However, the inserted stretch of amino acidsmight not be the op-
timal sequence for the enzyme’s enantioselectivity. Therefore,
it would be worthwhile to optimize the enantioselectivity of this
loop hybrid by randomizing the inserted loop region on these
Table 1. Activity and Enantioselectivity of the Constructed Loop
Mutants
Variant Conversion (%) ee (%)
Enantiomer Formed
in Excess
WT LipA 28.2 ± 1.0 12.9 ± 1.1 R-()-IPG
WT 1CEX 62.8 ± 6.1 +40.5 ± 2.4 S-(+)-IPG
1CEX 29.7 ± 1.0 +26.48 ± 1.6 S-(+)-IPG
AXE 20.9 ± 1.9 +6.0 ± 0.7 S-(+)-IPG
n = 3.






WT LipA 0.53 ± 0.33 1.05 ± 0.10
1CEX 1.00 ± 1.8 0.68 ± 0.53
1CEX L21G 1.17 ± 0.72 0.83 ± 0.11
1CEX L21Q 1.13 ± 3.2 0.52 ± 0.46
n = 3.786 Chemistry & Biology 15, 782–789, August 25, 2008 ª2008 Elsevpositions and assess which sequence is optimal. Consequently,
weanticipate that the knowledgegained from this studywill serve
as a lead for future protein engineering to create lipases that are
more enantioselective than those offered by nature.
SIGNIFICANCE
B. subtilis LipA has excellent properties with regard to its
kinetics for application in industrial biocatalysis of enantio-
pure b-adrenergic receptor antagonists and, in particular,
of their chiral building block 1,2-O-isopropylidene-sn-glyc-
erol (IPG). Nevertheless, its enantioselectivity toward these
substrates is modest, and, moreover, it is directed toward
the unwanted enantiomer of IPG. From its crystal structure,
it is known that LipA has a relatively open active-site cleft. It
was previously demonstrated that a drastic change in amino
acid sequence and active-site architecture can give rise to
altered enzyme function. This implies the replacement of
several of the enzyme’s surface loop structures. Thus, we
hypothesized that extending a loop lining the active-site
cleft and consequently narrowing it, might improve and in-
vert the enzyme’s enantioselectivity. Homologs of LipA with-
out a lid-like structure were identified, and the LipA hybrids
were rationally designed. Exchange of loops from F. solani
cutinase and P. purpurogenum acetylxylan esterase re-
sulted in active LipA hybrids, which showed an inverted
enantioselectivity. The enantioselectivity of the cutinase
hybrid, being the more promising variant of the two, was
further evolved by directed evolution. Thus, variants with
Figure 3. Activity and Enantioselectivity of Selected L21 Variants
n = 3.
Figure 4. Activity and Enantioselectivity of Selection T20X/L21G and
T20X/L21Q Double Mutants
T20X/L21G double mutants are shown on the left, and T20X/L21Q double
mutants are shown on the right. n = 3.ier Ltd All rights reserved
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selection assay and were characterized.
From an engineering point of view, this work extends the
use of enzyme engineering by grafting loops near the active
site. The combination of rational design of the hybrids and
directed evolution on specific hotspots has proven success-
ful. Our work, therefore, provides novel, to our knowledge,
perspectives on the evolution of enzyme enantioselectivity,
and can lead to an application in the improved synthesis of
enantiopure b-adrenergic receptor antagonists.
EXPERIMENTAL PROCEDURES
Computational Design of the Loop Mutants
B. subtilis LipA has an a/b-hydrolase fold that is very similar to that of cutinase
from F. solani (Protein Data Bank entry 1CEX [Longhi et al., 1997]) and that of
acetylxylan esterase (AXE) from P. purpurogenum (PDB entry 1G66 [Ghosh
et al., 1999]) (Van Pouderoyen et al., 2001). The homology of the enzymes
was calculated by using the SSM server (http://www.ebi.ac.uk/msd-srv/ssm
[Krissinel and Henrick, 2005]). A superposition of LipA and cutinase structures
showed that the 42–53 loop of cutinase is equivalent to residues 12–20
(Figure 1A). For AXE, residues 12–23 are equivalent to residues 11–20 in LipA
(Figure 1A). By means of the SWISS-MODEL server, protein structure homol-
ogy models were computed by using wild-type LipA as a template (PDB entry
1ISP) (http://swissmodel.expasy.org/workspace [Arnold et al., 2006]). Struc-
ture-based sequence alignments of the constructed models and LipA in the
presence of the phosphonate ester ofS-(+)-IPG (PDBcode 1R50)were created
with 3DCoffee (O’Sullivan et al., 2004). Modeler version 9.1 (Sali and Blundell,
1993), as implemented in the Biskit structural bioinformatics framework (Grun-
berg et al., 2007), was used to generate the resulting models (Figures 1B–1E).
Plasmids, Bacterial Strains, and Media
E. coli HB2151 (K12 D(lac-pro), ara, nalr, thi/F0, proAB, laqIq, lacZD-M15)
and pCANTAB 5E were purchased from Pharmacia (Amersham Pharmacia
Biotech, Uppsala, Sweden). E. coli K-12 PA340/T6 (thr-1, leuB6(Am),
fhuA2, lacY1, glnV44(AS), gal-6, l, gdhA1, hisG1(Fs), rfbD1, galP63,
D(gltB-gltF)500, rpsL9, malT1(lR), xylA7, mtlA2, DargH1, thi-1) was kindly
provided by the E. coli Genetic Stock Center (Yale University, New Haven,
CT). 2xTY medium contained: bactotrypton (1.6% w/v), bacto yeast extract
(1% w/v), and sodium chloride (0.5% w/v). As antibiotic agents, ampicillin
(100 mg.ml1), and streptomycin (100 mg.ml1) (Duchefa Biochemie, Haarlem,
The Netherlands) were used. M8 minimal medium contained Na2HPO4.7H2O
(4 g.l1), KH2PO4 (15 g.l
1), and sodium chloride (2.5 g.l1).
Chemicals
Both enantiomers of aspartate esters of IPG as well as both enantiomers of
butylphosphonate esters of IPG were synthesized by Syncom BV (Groningen,
The Netherlands). Butyrate esters of both enantiomers of IPG were kindly
provided by M.T. Reetz (Max-Planck Institut fu¨r Kohlenforschung, Mu¨lheim,
Germany). p-nitrophenyl caprylate was purchased from Sigma Chem. Co.
(Axel, The Netherlands). Supplemental amino acids (Thr, Arg, Leu, His
[10 mg.l1]) were purchased from Sigma-Aldrich (Steinheim, Germany).
Construction of the Loop Mutants
The LipA encoding gene (GenBank accession number M74010) was cloned in
the phagemid pCANTAB 5E, downstream of a modified g3p signal sequence
(Dro¨ge et al., 2003b). To introduce the 1CEX 42–53 loop, an overlapping PCR
strategy was used. All primers used in the reactions were purchased from In-
vitrogen (Groningen, The Netherlands) (for sequences, see Table S1 available
online). In the first step, the 42–53 loopwas constructed by using primer 1CEX-
for in combination with LipAlooprev and primer 1CEXrev in combination with
LipAloopfor. The AvaI restriction site, indicated in bold italics, was inserted
to make restriction analysis possible. The two overlapping PCR ‘‘half frag-
ments’’ were purified and used as a template in a second PCR step with the
flanking primers LipAloopfor and LipAlooprev.Chemistry & Biology 15, 7To construct the AXEmutant, the same PCR strategy was followed by using
primer AXEfor in combination with LipAlooprev and primer AXErev in combi-
nation with LipAloopfor. The BamHI restriction site, indicated in bold italics,
was put in to make restriction analysis possible. In a second PCR step, the ob-
tained overlapping PCR fragments were combined by using LipAloopfor and
LipAlooprev primers.
Mutant libraries on position 21 in the CEX loop were constructed by using
primer 1CEXN51BamHIFor in combination with LipAlooprev and primer
1CEXN51BamHIRev in combination with LipAloopfor. The BamHI restriction
site, indicated in bold italics, was put in to make restriction analysis possible.
In a second PCR step, the obtained overlapping PCR fragments were
combined by using LipAloopfor and LipAlooprev primers.
Mutant libraries on position 20 in the CEX loop with either a Gln (CAA) or
a Gly (GGG) at position L21 (underlined) were constructed by using primer
1CEX5051XBamFor in combination with LipAlooprev and primer 1CEX5051X-
BamRev in combination with LipAloopfor. The BamHI restriction site, indicated
in bold italics, was put in tomake restriction analysis possible. In a second PCR
step, the obtained overlapping PCR fragments were combined by using
LipAloopfor and LipAlooprev primers.
Recombinant DNA procedures were carried out as described by Sambrook
et al. (1989). Plasmid DNAwas prepared by using theQiaprep SpinMiniprep kit
(QIAGEN, Hilden, Germany). DNA purification was performed by using the Qia-
quick Gel Extraction kit (QIAGEN, Hilden, Germany). The gene fragment was
digested with AgeI and HindIII (New England Biolabs) and was cloned in
E. coli HB2151 into the AgeI and HindIII sites of the phagemid pCANTABLip-
CH (Dro¨ge et al., 2003b). The constructs were sequenced to verify the correct
base pair order.
Isolation of the Periplasmic Fraction
E. coli HB2151 or E. coli K-12 PA340/T6 were grown in 50 ml tubes containing
10 ml 2xTY medium, ampicillin, and isopropyl-b-d-galactopyranoside (IPTG,
1 mM). The tubes were incubated at 28C at 250 rpm for 16 hr. The OD600
was recorded, and the cells were harvested and resuspended in Tris-HCl
buffer (10 mM, pH 7.4). After centrifugation, the cells were resuspended in
200 ml buffer containing Tris-HCl (10 mM, pH 8.0), sucrose (25% w/v), EDTA
(2 mM), and lysozyme (0.5 mg.ml1). After incubation on ice for 20 min, 50 ml
buffer containing Tris-HCl (10 mM, pH 8.0), sucrose (20% w/v), and MgCl2
(125 mM) was added. The suspension was centrifuged, and the supernatant,
containing the periplasmic fraction, was isolated and used as enzyme solution
in the IPG ester assay. The protein content of this fraction was determined by
performing a Bradford assay in triplicate by using bovine serum albumin (BSA)
as a standard (Pierce, Rockford, IL).
1,2-O-Isopropylidene-sn-Glycerol Ester Assay
Wild-type cutinase and periplasmic fractions were diluted with MOPS buffer
(0.07 M, pH 7.5), containing BSA (0.2% w/v), to a final volume of 100 ml. Ref-
erences were diluted correspondingly but contained no enzyme solution.
The esters of IPG (1 mM) were dissolved in 10 ml MOPS buffer (0.07 M, pH
7.5), containing Tween 80 (14.3% w/v), and were diluted to 50 ml with
MOPS buffer (0.07 M, pH 7.5). A total of 500 ml substrate solution was added
to the enzyme solution, and the final mixture was incubated in a water bath at
32C. After incubation, 400 ml saturated NaCl solution and 10 ml internal
standard solution (racemic 3-hexene-1-ol, 5 mg.ml1 assay buffer) was added
to the sample solution, and the aqueous solution was extracted twice with 1ml
ethyl acetate. GC analysis was performed as described byDro¨ge et al. (2003a).
One unit (U) is defined as the amount of enzyme that hydrolyses 1 mmol IPG
ester per minute. Enantiomeric excesses, ee, were calculated according to
Chen et al. (1982) and were defined as the ability of the enzyme to distinguish
between enantiomers. All data were expressed as mean ± SEM. The statistical
significance of differences was tested at a significance level of p < 0.05 by
using a two-tailed Student’s t test.
Determination of KM
E. coli HB2151 was grown for 16 hr at 37C in 1 l 2xTY medium supplemented
with 100 mg.ml1 ampicillin and 1 mM IPTG. The periplasmic fraction was
isolated as described above. The total protein content was determined by
performing a Bradford assay with bovine serum albumin (BSA) as a standard
(Pierce, Rockford, IL). To determine the expression level of LipA, parent mutant82–789, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 787
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separating and a 3% stacking gel (Invitrogen, Groningen, The Netherlands).
Molecular mass markers were purchased from Invitrogen.
To obtain a KM value, the IPG assay was performed in triplicate. The
KM value for each enantiomer was obtained by fitting the experimental data
from Eadie-Hofstee plots. The mean and SEM of three measurements were
calculated.
Selection on Selective Minimal Medium
The aspartate auxotroph E. coli K-12 PA340/T6 was made chemically compe-
tent and transformed with 50 ng mutant plasmid DNA of the library at position
L21 in the loop (Sambrook et al., 1989). Growth selection was performed as
described by Boersma et al. (2008). Cells were starved by incubation in
0.9% NaCl for 2 hr at 37C and were plated onto selective minimal medium
agar plates supplemented with either aspartate or an ester of aspartate cou-
pled to enantiopure IPG. To increase selection pressure, a phosphonate inhib-
itor, i.e., a phosphonate ester of enantiopure IPG, was added to the medium.
After 2 days of growth, 16 colonies were randomly selected and sequenced.
The periplasm was isolated, and activity and enantioselectivity were tested
toward the real substrate, a racemic IPG butyrate ester.
As a second generation of LipA mutants, a saturated library was created at
position T20 in the loopwhile L21wasmutated in either a glutamine or a glycine
residue. Mutants were selected by using the growth-selection procedure as
described above. Colonies were selected and sequenced. The periplasm
was isolated, and activity was tested on racemic IPG butyrate.
SUPPLEMENTAL DATA
Supplemental Data include one table and can be foundwith the article online at
http://www.chembiol.com/cgi/content/full/15/8/782/DC1/.
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